BJRI vs TSLA

BJRI's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given a dangerously high Debt/Equity ratio of 1.41 and extremely low liquidity ratios (Current Ratio: 0.36, Quick Ratio: 0.21). While the company shows strong earnings surprise history and recent EPS growth of 130.8% YoY, these gains are likely driven by one-time or cyclical factors, as evidenced by negative operating margins (-0.13%) and inconsistent profitability. The stock trades at a premium to its intrinsic value and Graham number, suggesting overvaluation despite modest revenue growth. Analysts recommend 'buy' but with limited conviction, as the technical trend is bearish and insider sentiment is neutral.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.